KRAS and cancer: A higher rate of KRAS mutation was found in stage II (48.49%) compared with that in stage I, stage III and stage IV (36.84%, 40.45%, 34.52%, respectively) cancers (p = 0.023) and in non-smokers compared with smokers (46.6% vs34.98%, p = 0.001).